Wed, Oct 1, 2014, 7:00 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

MCG Capital Corporation Message Board

  • wareham2620 wareham2620 Sep 18, 2008 9:48 AM Flag

    TheStreetReport Date: September 14, 2008 PAGE 1

    Report Date: September 14, 2008 PAGE 1
    MCGC BUSINESS DESCRIPTION
    MCG Capital Corporation is a private equity firm
    specializing in investments in middle market
    companies. It seeks to invest in small to mid sized
    companies. The firm prefers to invest in
    acquisitions, growth financings, and leveraged
    buyouts.
    STOCK PERFORMANCE (%)
    3 Mo. 1 Yr. 3 Yr (Ann)
    Price Change -33.55 -78.44 -44.41
    GROWTH (%)
    Last Qtr 12 Mo. 3 Yr CAGR
    Revenues -38.04 -0.55 17.11
    Net Income -282.67 -140.67 NA
    EPS -252.38 -130.14 NA
    RETURN ON EQUITY (%)
    MCGC Ind Avg S&P 500
    Q2 2008 -6.27 11.37 11.94
    Q2 2007 14.53 20.42 17.02
    Q2 2006 12.52 19.49 15.88
    P/E COMPARISON
    n/m
    MCGC
    42.74
    Ind Avg
    20.68
    S&P 500
    EPS ANALYSIS┬╣ ($)
    2008
    Q2 -0.96
    Q1 0.04
    2007 Q4 -
    0.08
    Q3 0.37
    Q2 0.63
    Q1 0.52
    2006
    Q4 0.52
    Q3 0.42
    Q2 0.43
    Q1 0.50
    NA = not available NM = not meaningful
    1 Compustat fiscal year convention is used for all fundamental
    data items.
    Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years
    2007 2008
    2
    4
    6
    8
    10
    12
    14
    16
    18
    20
    22
    Rating History
    BUY HOLD SELL HOLD
    0
    10
    20
    Volume in Millions
    COMPUSTAT for Price and Volume, TheStreet.com Ratings, Inc. for Rating History
    RECOMMENDATION
    We rate MCG CAPITAL CORP (MCGC) a SELL. This is driven by a number of negative factors, which we
    believe should have a greater impact than any strengths, and could make it more difficult for investors to
    achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen
    in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing
    return on equity, weak operating cash flow and generally disappointing historical performance in the stock
    itself.
    HIGHLIGHTS
    MCG CAPITAL CORP has exprienced a steep decline in earnings per share in the most recent quarter in
    comparison to its performance from the same quarter a year ago. Earnings per share have declined over the
    last year. We anticipate that this should continue in the coming year. During the past fiscal year, MCG
    CAPITAL CORP reported lower earnings of $1.44 versus $1.87 in the prior year. For the next year, the market is
    expecting a contraction of 40.3% in earnings ($0.86 versus $1.44).
    The company, on the basis of change in net income from the same quarter one year ago, has significantly
    underperformed when compared to that of the S&P 500 and the Capital Markets industry. The net income has
    significantly decreased by 282.7% when compared to the same quarter one year ago, falling from $38.05
    million to -$69.50 million.
    Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This
    is a signal of major weakness within the corporation. Compared to other companies in the Capital Markets
    industry and the overall market, MCG CAPITAL CORP's return on equity significantly trails that of both the
    industry average and the S&P 500.
    Net operating cash flow has decreased to $14.80 million or 34.39% when compared to the same quarter last
    year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
    Despite any intermediate fluctuations, we have only bad news to report on this stock's performance over the
    last year: it has tumbled by 78.44%, worse than the S&P 500's performance. Consistent with the plunge in the
    stock price, the company's earnings per share are down 252.38% compared to the year-earlier quarter.
    Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's
    sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over
    the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a
    good buy right now.

 
MCGC
3.53+0.01(+0.28%)Oct 1 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.